FIELD: pharmaceuticals.
SUBSTANCE: invention relates to pharmaceuticals, medicine and veterinary medicine, in particular to the development of a synthetic analgesic of peptide nature and a method of pain relief with it.
EFFECT: peptide compound is proposed which is Ac-RERR-NH2, having an analgesic effect, a pharmaceutical composition comprising said peptide compound, and a method for pain management.
12 cl, 2 dwg, 5 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
ANALGESIC SUBSTANCE OF ENDOGENOUS NATURE, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHODS OF USE THEREOF | 2023 |
|
RU2823100C2 |
MEANS FOR EFFECTIVE CUPPING OF ACUTE AND/OR CHRONIC PAIN SYNDROME AND METHOD OF ITS APPLICATION | 2016 |
|
RU2622980C1 |
FAMILY OF PEPTIDES POSSESSING ANALGESIC ACTIVITY | 2005 |
|
RU2286169C1 |
COMPOSITION AND METHOD FOR PRODUCING PEPTIDE ANALGETIC AGENT | 2017 |
|
RU2669386C1 |
ANALGESIC AGENT OF PEPTIDE STRUCTURE BASED ON TRIDECAPEPTIDE CONTAINING D-OCTAARGININE VECTOR | 2013 |
|
RU2538727C1 |
SYNTHETIC ANALGESIC AGENT AND METHOD FOR TREATMENT BASED ON THIS AGENT | 2006 |
|
RU2322977C1 |
ANALGESIC AGENT AND THERAPY OF PAIN SYNDROME OF VARIOUS AETIOLOGIES BY USING SAID AGENT | 2007 |
|
RU2367432C2 |
PEPTIDE AGENT POSSESSING ANALGESIC ANTI-INFLAMMATORY ACTION, AND BASED DOSAGE FORMS | 2012 |
|
RU2528094C2 |
ANALGESIC AGENT OF PEPTIDE STRUCTURE OF UNDERCAPEPTIDE CONTAINING D-OCTAARGININE VECTOR | 2013 |
|
RU2541127C1 |
NEPHOPAM SUPPOSITORIES FOR THE TREATMENT OF ACUTE AND CHRONIC PAIN SYNDROME ON A LIPOPHILIC BASIS AND THE METHOD FOR THEIR PREPARATION | 2017 |
|
RU2661618C1 |
Authors
Dates
2018-06-04—Published
2017-05-03—Filed